H.C. Wainwright Keeps Their Buy Rating on IVERIC bio (ISEE)

H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on IVERIC bio (ISEE – Research Report) today and set a price target of $3...

Related Keywords

New York ,United States ,Samir Chandrakant Patel ,Matthew Caufield ,Dugel Pravin ,Davidr Guyer ,Ocuphire Pharma , ,Research Report ,Moderate Buy ,